Officer Dennis Mulroy Files to Sell Additional $1.1M in Stock
ANAB has more than doubled off its 52-week low of $11.402.
Summary
AnaptysBio officer Dennis Mulroy has filed to sell another $1.1 million in company stock, extending a recent trend of significant insider dispositions that contrasts with the company's share repurchase program.
Key Events · Ownership and Investor Activity · ANAB
-
Officer Files Intent to Sell
Officer Dennis Mulroy has filed a Form 144 to sell 20,000 shares of common stock, valued at approximately $1,105,940.
-
Continuation of Selling Pattern
This filing extends a recent trend of significant insider selling by Mulroy, who has sold over $15 million in shares in the past three months.
-
Acquisition via Stock Option Exercise
The shares intended for sale were acquired through a stock option exercise on the same day as the proposed sale.
-
Contrasts with Share Repurchase Program
The ongoing insider selling occurs despite the company's recent announcement of a $100 million share repurchase program on May 12, 2026.
Analysis · ANAB · Life Sciences
Officer Dennis Mulroy has filed a Form 144 to sell an additional $1.1 million worth of common stock. This continues a pattern of significant insider selling from Mulroy, who has already sold over $15 million in shares in the past three months. This ongoing selling by a key officer contrasts with the company's recent announcement of a $100 million share repurchase program.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ANAB was trading at $56.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.